Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 358

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 358
---
any provision herein that may be defective or inconsistent with any other provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement; provided that, in each case, such provisions do not
adversely affect the interests of the Holders;

as may be necessary or appropriate to ensure that the CVRs are not subject to
registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, and to ensure that the CVRs are not subject to any similar registration or
prospectus requirement under applicable securities laws outside of the United States; that, in each case, such provisions do not adversely affect the interests of the Holders;

to evidence the succession of another Person as a successor Rights Agent or the Representative and the assumption by any such successor of
the covenants and obligations of the Rights Agent or the Representative, as applicable, herein in accordance with and ; or

any other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement; that, in
each case, such addition, elimination or change does not adversely affect the interests of the Holders in any material respect.

Without
the consent of any Holders, the Representative, Purchaser and the Rights Agent, in their sole and absolute discretion, at any time and from time to time, may enter into one or more amendments hereto, to reduce the number of CVRs which, and only in
the event that, any Holder agrees to renounce and abandon such Holder’s rights under this Agreement in accordance with .

Promptly after the execution by the Representative, Purchaser and the Rights Agent of any amendment pursuant to the provisions of this
, Purchaser shall mail (or cause the Rights Agent to mail) a notice thereof by first class mail to the Holders at their addresses as they appear on the CVR Register, setting forth such amendment.

A-101

Subject to (which amendments pursuant to may be made without the consent of the Holders), with
the consent of the Acting Holders, whether evidenced in writing or taken at a meeting of the Holders, the Representative, Purchaser and the Rights Agent may enter into one or more amendments hereto for the purpose of adding, eliminating or changing
any provisions of this Agreement, even if such addition, elimination or change is materially adverse to the interests of the Holders.

Promptly after the execution by Purchaser the Representative